The Ministry of Health and Community Protection warned of fake and contaminated medical products used to treat hepatic venous obstruction, and called on all health facilities and private health care practitioners to take the necessary steps to protect patients from their harm.
The ministry issued a circular, which addressed it to all health facilities, and health-care practitioners in the private sector, through which it warns of the drug "(Defitelio) Defibrotide 200mg Vials of 2.5ml (80 mg / ml) Solution for Infusion", which is used to treat hepatic venous obstruction. After the World Health Organization reported that the defective injection packages of 200 mg medicine were found in Australia, Saudi Arabia, and Latvia, it was confirmed that these counterfeit products do not contain the active substance of the product as they are contaminated with mold "Cladosporium sp" and "Aspergillus". niger, "and reports have shown that producers are imitating their identity and composition They are and their source.
The original manufacturer GENTIUM SRL confirmed that the manufacturers were not manufactured in its factory, and the original 200-mg defibrotide drug with the operating number 0286 was exported to Argentina, Hong Kong, Malaysia, Singapore and Turkey, and the original 200-mg defibrotide drug with the operating number 0126 was exported to Australia, Jordan, Kuwait, Lebanon, New Zealand, Qatar and Singapore Turkey and the United Arab Emirates, and it is important for all countries to inspect and check for the presence of counterfeit products, regardless of where these products were found, and stressed that the two operations should not be used if they are available.